Welcome to our dedicated page for Definitive Healthcare SEC filings (Ticker: DH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Definitive Healthcare Corp. (NASDAQ: DH) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. Definitive Healthcare is a Delaware corporation focused on healthcare commercial intelligence and healthcare market data and analytics, and its filings provide formal detail on its operations, governance and financial reporting.
Investors can review current reports on Form 8-K, which the company uses to disclose material events such as quarterly financial results, leadership changes and board updates. For example, Form 8-K filings reference earnings press releases for specific quarters and describe items like results of operations, director resignations, committee appointments and executive leadership changes.
In addition to 8-Ks, users can access Definitive Healthcare’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which contain audited and interim financial statements, management’s discussion and analysis, risk factors, and segment and non-GAAP metric disclosures. These documents expand on metrics highlighted in earnings releases, including Adjusted EBITDA, Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Unlevered Free Cash Flow.
Stock Titan’s platform enhances these filings with AI-generated summaries that explain key sections, highlight important changes and clarify complex accounting or non-GAAP reconciliations. Real-time updates from EDGAR help ensure that new filings, including any Form 4 insider transaction reports or proxy statements related to executive compensation and governance, appear promptly.
For users researching DH stock, this page offers a structured way to read, compare and understand Definitive Healthcare’s regulatory history, financial reporting practices and corporate actions without manually parsing every line of each SEC document.
Definitive Healthcare Corp. reporting person Casey Heller, the company's Chief Financial Officer, disclosed a transaction on 10/01/2025 in which 8,300 shares of Class A common stock were disposed of at $3.56 per share. After the reported sale, the filing shows the reporting person beneficially owns 1,081,421 shares. The form explains the transaction reflects shares withheld by the issuer to satisfy the reporting person’s tax withholding obligations related to the vesting and settlement of previously reported restricted stock units. The filing is an individual Form 4 and was signed by an attorney-in-fact on behalf of the reporting person.
Kevin Coop, who is listed as both Chief Executive Officer and a Director of Definitive Healthcare Corp. (DH), reported a transaction on 10/01/2025. The report shows a Code F(1) transaction disposing of 37,593 shares of Class A common stock at a price of $3.56 per share. The filing explains these shares were withheld by the issuer to satisfy the reporting person’s tax withholding obligations related to the vesting and settlement of previously reported restricted stock units. After the withholding, the reporting person beneficially owned 3,584,788 shares, held directly. The form is signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025.
Definitive Healthcare Corp. (DH) insider Jason R. Krantz reported a transaction on 09/14/2025. The filing shows a disposition of 4,093 shares of Class A common stock at $4.15 per share, recorded as a sale to satisfy tax withholding related to vested restricted stock units. After the transaction, Mr. Krantz directly beneficially owns 1,079,380 shares and indirectly owns 450,000 shares held in trust by DH Holdings (formerly the Jason R. Krantz 2009 Trust). The filing was signed by an attorney-in-fact on 09/16/2025.
On 08/01/2025, Definitive Healthcare Corp. (DH) Chief Financial Officer Casey Heller filed a Form 4 reporting a routine tax-withholding transaction. The company withheld 1,244 Class A common shares (transaction code F) at an implied price of $3.74 per share to cover federal taxes triggered by the vesting of previously granted restricted stock units. Following the withholding, Heller still directly owns 1,089,721 shares, preserving the vast majority of his stake. No open-market purchase or discretionary sale occurred, and there were no derivative security movements disclosed. The filing is administrative in nature and does not indicate a change in role, outlook, or insider sentiment.
Form 4 filed 08/05/2025 discloses that Definitive Healthcare (DH) Chief Operating Officer Kate Marie Shamsuddin satisfied tax-withholding obligations from previously granted restricted stock units. On 08/01/2025 she surrendered 4,741 Class A common shares to the issuer at an imputed price of $3.74; no cash was received. The transaction is coded “F,” indicating share withholding rather than an open-market sale.
After the withholding, Shamsuddin directly owns 694,149 DH shares. No derivative securities were acquired or disposed of, and no additional insider transactions were reported. The surrendered shares equal roughly 0.7 % of her post-transaction holdings, suggesting minimal impact on insider ownership concentration or public float.